Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Philip Hazell, conjoint professor of child and adolescent psychiatry
  1. University of Sydney, Thomas Walker Hospital, NSW 2138, Australia
  1. Philip.Hazell{at}sswahs.nsw.gov.au

    Adding cognitive behaviour therapy to SSRIs is unlikely to improve outcomes

    Around 3-5% of adolescents are affected by clinical depression worldwide.1 2 3 4 Although specific data on depression are not available, an Australian survey found 26% of adolescents with mental disorders were treated in general or paediatric practice, while only 9% received care from specialist mental health services.3

    Episodes of depression generally last about seven to nine months. Probability of relapse is 40% within two years and 70% after five years.5 Depression can be devastating to a young person's academic and social development and can adversely affect family relationships, especially if the problems are misunderstood.

    Optimal treatment for depression in adolescents is unclear. Concern about an increased rate of suicidal behaviours with antidepressants in trials in adolescents has led to safety warnings about their use in Europe, North America, and Australasia.6 Should adolescents with depression be prescribed antidepressants, and if so, should they be given only with psychotherapy?

    In this week's BMJ, a randomised controlled trial (adolescent depression antidepressant and psychotherapy trial; ADAPT) by Goodyer …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular